From ScolrPharma, USA
Shasun Pharmaceuticals has acquired the global rights from ScolrPharma, USA, to develop and commercialise Ibuprofen 12 hour extended release OTC tablets as well as the associated controlled release technology (CDT) along with global rights of Nuprin trademark, a well known brand in Analgesics.Powered by Capital Market - Live News